Familial hypobetalipoproteinemia (FHBL), caused by apolipoprotein B (APOB) variants, disrupts APOB-containing lipoprotein synthesis, leading to reduced serum total cholesterol, low-density lipoprotein ...
Morning Overview on MSN
UT Southwestern just uncovered a hidden 'master switch' that decides how much cholesterol the liver pumps into the bloodstream — and how to turn it off
Every day, your liver assembles billions of tiny cholesterol-carrying particles and ships them into your blood. How many it ...
The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and ...
Researchers at UT Southwestern Medical Center have identified a protein that acts as a key regulator of how the liver releases cholesterol carrying ...
LDL cholesterol still drives treatment decisions in assessing heart disease risk, but a new study suggests apolipoprotein B (apoB), which measures artery-clogging particles, could do a better job. In ...
Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total ...
Hosted on MSN
Cholesterol and ApoB don't predict death. This does.
The first time I heard those six words, they were jarring. I was only 23. And they sounded like a threat—spoken by a much older, presumably more knowledgeable, attending physician. The insult that ...
People whose LDL cholesterol is in the normal range—even those without metabolic risk factors—may yet have levels of apolipoprotein B (apoB) that predict an elevated risk of future atherosclerotic ...
(A) Due to PNPLA3 defects. Genetic defects in PNPLA3 result in decreased hydrolysis of triglycerides to fatty acids. This leads to increased intrahepatic triglycerides and decreased exportation of ...
Excess apolipoprotein B (apoB) levels—in amounts higher than expected based on LDL cholesterol levels alone—provide important clinical information about the risk of future cardiovascular disease not ...
Share on Pinterest A new study suggests that not only is apoB testing effective for guiding cholesterol treatment, but also cost-effective. Image credit: aire images/Getty Images A study suggests that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results